Review article: The potential role for photodynamic therapy in the management of upper gastrointestinal disease

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 3, 2001, Pages 311-321

  Barr, H ^a   Dix, A J ^a   Kendall, C ^a   Stone, N ^a  

^a GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; GLYCINE; HEMATOPORPHYRIN; HEME; PHOTOFRIN; PHOTOSENSITIZING AGENT; PORPHOBILINOGEN; PROTOPORPHYRIN; TETRAKIS(3 HYDROXYPHENYL)CHLORIN;

ADVANCED CANCER; BARRETT ESOPHAGUS; BILIARY TRACT CANCER; CANCER PALLIATIVE THERAPY; CLINICAL TRIAL; DYSPLASIA; ESOPHAGUS CARCINOMA; HUMAN; PANCREAS CANCER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; STOMACH CARCINOMA; TREATMENT INDICATION; TREATMENT OUTCOME;

BARRETT ESOPHAGUS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; HELICOBACTER INFECTIONS; HUMANS; PALLIATIVE CARE; PANCREATIC NEOPLASMS; PATIENT SELECTION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; STOMACH NEOPLASMS;

EID: 0035123801     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.00936.x     Document Type: Review

References (79)

1. Life: Past, present and future
2. The major protein import receptor of plastids is essential for chloroplast biogenesis
3. A functional model for O-O bond formation by the O2-evolving complex in Photosystem II
4. Mitochondral evolution
5. Diagnosis and management of porphyria
6. The origin of red algae and the evolution of chloroplasts
7. Die photodynamische erscheinung
8. Zur behandlung der hautcarcinoma mit fluorescierenden stoffen Arch
9. Activated dyes as antitumor agents
10. Hematoprphyrin derivative and laser photoradiation in the treatment of lung cancer
11. Palliation of esophageal malignancy with photoradiation therapy
12. Svanberg K, Detection of adenocarcinoma in Barrett's oesophagus by means of laser-induced fluoresecence
13. Endoscopic fluorescence detection of high-grade dysplasia in Barrett's oesophagus
14. Beyond white light endoscopy: The prospects for endoscopic optical biopsy
15. Selective necrosis in dimethylhydrazine-induced rat colon tumors using phthalocyanine therapy
16. Photodynamic therapy in Gastroenterology
17. Photodynamic therapy using ALA induced PPIX for experimental pancreatic cancer-prolonged animal survival
18. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd: YAG laser for palliation of esophageal cancer: A multicentre randomized trial
19. Endoscopic treatment of upper gastrointestinal cancer. Current medical literature
20. Role of photodynamic therapy in the management of advanced esophageal cancer
21. Photodynamic therapy for obstructing esophageal cancer: Light dosimetry and a randomized comparison with Nd: YAg laser therapy
22. Photodynamic therapy for colorectal cancer: A quantitative pilot study
23. Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasia
24. Photodynamic therapy of early squamous cell cancers of the esophagus
25. Preliminary results of hematoporphyrin derivative-laser treatment for 13 cases of early esophageal carcinoma
26. Photodynamic therapy of early squamous cell carcinomas of the esophagus: A review of 31 cases
27. Long-term survival after photodynamic therapy for esophageal cancer
28. Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 6 30 nm light irradiation after sensitization with Photofrin II
29. Tetra (m-hydroxyphenyl) chlorin clinical photodynamic therapy of early bronchial and oesophageal cancers
30. Barrett's esophagus
31. Barrett's esophagus, dysplasia, and adenocarcinoma
32. Ablation treatment for Barrett's oesophagus: What depth of tissue destruction is needed?
33. Electromagnetic simulation of laser-induced fluorescence in bronchial tissue and predicted optical scattering behaviour
34. Kinetics, localization, and mechanism of 5-aminolaevulinic acid-induced porphyrin accumulation in normal and Barrett's-like rat esophagus
35. Barrett's esophagus: Treatment with 5-aminolevulinic acid photodynamic therapy
36. Eradication of high grade dysplasia in columnar-lined (Barrett's) oesophagus using photodynamic therapy with endogenously generated protoporphyrin IX
37. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus
38. Timing of illumination is essential for effective and safe photodynamic therapy: A study in the normal rat oesophagus
39. Photodynamic therapy for Barrett's oesophagus: A prospective randomised trial
40. Photodynamic therapy in Barrett's esophagus after local administration of 5-aminolaevulinic acid
41. Photodynamic therapy for the treatment of early carcinoma in Barrett's esophagus
42. Centering balloon to improve esophageal photodynamic therapy
43. Photodynamic therapy for Barrett's esophagus. Follow-up in 100 patients
44. Photodynamic therapy of gastric cancer
45. Photodynamic ablation of early gastric cancers of the stomach by means of mTHPC and laser irradiation
46. Photodynamic therapy and its potential for treatment of gastrointestinal malignancies and precancerous conditions
47. Aminolaevulinic acid-induced photodynamic therapy in the treatment of dysplastic Barrett's oesophagus and adenocarcinoma
48. Endoscopic aspiration mucosectomy as curative endoscopic surgery: Analysis of 24 early gastric cancers
49. Surgical treatment in proximal bile duct cancer: Single-centre experience
50. Hilar cholangiocarcinoma: Patterns of spread, the importance of hepatic resection for curative operation, and a pre-surgical clinical staging system
51. Photodynamic therapy of nonresectable cholangiocarcinoma
52. Photodynamic therapy of cholangiocarcinoma cancer
53. Photodynamic therapy for palliation of unresectable pancreatic cancer
54. The biology of photodynamic therapy in the gastrointestinal tract
55. Photodynamic therapy for malignant tumours of the Ampulla of Vater
56. The killing of Helicobacter pylori by low-power laser light in the presence of a photosensitiser
57. Gastrointestinal tumours: Let there be light
58. Endogenous protoporphyrin, a clinically useful photosensitiser for photodynamic therapy
59. Barrett's esophagus with high-grade dysplasia: An indication for esophagectomy?
60. Surgical management of high-grade dysplasia in Barrett's esophagus
61. Endoscopic surveillance of Barrett's oesophagus. Does it help?
62. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus
63. Outcome of adenocarcinoma in Barrett's esophagus in endoscopically surveyed and non-surveyed patients
64. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia
65. Radical esophageal resection for adenocarcinoma arising in Barrett's esophagus
66. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy
67. Resection for Barrett's mucosa with high-grade dysplasia: Implications for prophylactic photodynamic therapy
68. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: A pathological study
69. Photodynamic therapy of the normal rat stomacha comparative study between disulfonated aluminium phthalocyanine and 5-aminolevulinic acid
70. Photodynamic therapy for dysplastic Barrett's oesophagus: A prospective, double blind, randomised, placebo controlled trial
71. The histopathology of treated Barrett's esophagus
72. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation
73. Photothermal laser ablation of Barrett's oesophagus: Endoscopic and histological evidence of squamous re-epithelialisation
74. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus
75. Barrett's esophagus: Treatment with 5-aminolevulinic acid photodynamic therapy
76. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy
77. Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression
78. Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy
79. Endoscopic regression of Barrett's oesophagus during omeprazole treatment: A randomised double blind study